Company · CIK 0001668397 · SIC 8731 — Services-Commercial Physical & Biological Research · Nasdaq
Medpace Holdings, Inc. · MEDP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 SForm 4 → | Sep 25, 4:22 pm EDT | August J. TroendlePresident & CEO, Director, 10% Owner | 43,916 | $624.01 | $27,403,895 | 389,456 | −10.1% | |
| Sep 21, 2026 SForm 4 → | Sep 23, 4:05 pm EDT | August J. TroendlePresident & CEO, Director, 10% Owner | 70,901 | $626.62 | $44,428,151 | 433,372 | −14.1% | |
| Sep 17, 2026 SForm 4 → | Sep 21, 4:23 pm EDT | August J. TroendlePresident & CEO, Director, 10% Owner | 10,880 | $620.40 | $6,749,952 | 504,273 | −2.11% | |
| Sep 15, 2026 SForm 4 → | Sep 17, 4:39 pm EDT | August J. TroendlePresident & CEO, Director, 10% Owner | 24,741 | $621.00 | $15,364,149 | 515,153 | −4.58% | |
| Sep 15, 2026 MForm 4 → | Sep 17, 4:35 pm EDT | Susan E BurwigExec. VP, Operations | 3,000 | $166.73 | $500,190 | 65,984 | — | |
| Aug 27, 2026 SForm 4 → | Aug 31, 4:11 pm EDT | August J. TroendlePresident & CEO, Director, 10% Owner | 650 | $620.27 | $403,176 | 539,894 | −0.12% | |
| Aug 26, 2026 SForm 4 → | Aug 28, 4:32 pm EDT | Robert O. KraftDirector | 3,858 | $617.81 | $2,383,511 | 955 | −80.2% | |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:32 pm EDT | Robert O. KraftDirector | 3,858 | $84.36 | $325,461 | 4,813 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:35 pm EDT | Susan E BurwigExec. VP, Operations | 3,000 | — | — | 8,028 | — | |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:32 pm EDT | Robert O. KraftDirector | 3,858 | — | — | 0 | — |